title: Triple inhalers for obstructive airways disease: will they be useful?
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Barnes
mesh_terms: D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D058666:Adrenergic beta-2 Receptor Agonists / Q000008:administration & dosage*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D004983:Ethanolamines / Q000008:administration & dosage; D019317:Evidence-Based Medicine; D000068759:Formoterol Fumarate; D006801:Humans; D018727:Muscarinic Antagonists / Q000008:administration & dosage*; D009330:Nebulizers and Vaporizers; D011282:Pregnenediones / Q000008:administration & dosage; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D012602:Scopolamine Derivatives / Q000008:administration & dosage; D000069447:Tiotropium Bromide; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D058666:Adrenergic beta-2 Receptor Agonists; D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D004983:Ethanolamines; D018727:Muscarinic Antagonists; D011282:Pregnenediones; D012602:Scopolamine Derivatives; C120481:ciclesonide; D000068759:Formoterol Fumarate; D000069447:Tiotropium Bromide